Eosinophilic myocarditis in platelet-derived growth factor receptor α-rearranged myeloid neoplasm with central nervous system involvement: a case report
Abstract
Eosinophilic myocarditis is a rare inflammatory condition caused by eosinophilic infiltration of the myocardium, often associated with systemic or hematologic disorders.
We report a 31-year-old man with a newly diagnosed platelet-derived growth factor receptor α-rearranged myeloid neoplasm who presented with acute chest pain and elevated cardiac biomarkers. Echocardiography showed Loeffler-type apical involvement, coronary computed tomography angiography excluded obstructive coronary disease, and cardiac magnetic resonance (CMR) demonstrated acute non-ischemic inflammatory myocardial injury. During hospitalization, neurological symptoms revealed central nervous system involvement by the underlying myeloid neoplasm. Corticosteroids and targeted hematologic treatment resulted in marked clinical and radiologic improvement.
On long-term follow-up, CMR showed normal cardiac function with complete resolution of the inflammatory myocardial abnormalities and no residual fibrosis.
This case highlights the value of early multimodality cardiac imaging, etiologic diagnosis, and coordinated cardio-hematologic management in recognizing potentially reversible eosinophilic myocardial injury and limiting progression to irreversible cardiac sequelae.
References
- Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J 2025;46:3952-4041. DOI: https://doi.org/10.1093/eurheartj/ehaf192
- Brambatti M, Matassini MV, Adler ED, et al. Eosinophilic myocarditis. J Am Coll Cardiol 2017;70:2363-75. DOI: https://doi.org/10.1016/j.jacc.2017.09.023
- Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 2024;99:946-68. DOI: https://doi.org/10.1002/ajh.27287
- Venkataramany BS, Brar A, Ahart Z, et al. Eosinophilic myocarditis associated with chronic eosinophilic leukemia. JACC Case Rep 2025;30:104805. DOI: https://doi.org/10.1016/j.jaccas.2025.104805
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-405. DOI: https://doi.org/10.1182/blood-2016-03-643544
- Legrand F, Renneville A, MacIntyre E, et al. The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases. Medicine 2013;92:e1-9. DOI: https://doi.org/10.1097/MD.0b013e3182a71eba
- Piccirillo F, Mastroberardino S, Nafisio V, et al. Eosinophilic myocarditis: from bench to bedside. Biomedicines 2024;12:656. DOI: https://doi.org/10.3390/biomedicines12030656
- Kawano S, Kato J, Kawano N, et al. Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 2011;50:975-81. DOI: https://doi.org/10.2169/internalmedicine.50.4079
- Aggarwal HK, Jain D, Kaverappa V, et al. Idiopathic hypereosinophilic syndrome presenting as severe Loeffler’s endocarditis. Arq Bras Cardiol 2013;100:e43-6. DOI: https://doi.org/10.5935/abc.20130081
- Porkka K, Koskenvesa P, Lundán T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia. Blood 2008;112:1005-12. DOI: https://doi.org/10.1182/blood-2008-02-140665
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.